CIK 0001590560
- Large accelerated filer
uniQure N.V.
Sign in to watch- Ticker
- QURE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 339-970-7000
- Business address
- PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
- Former names
- uniQure B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $192,950
- in 1 filing, $193K under 10b5-1 plans
Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Balachandran Madhavan Director | Sale 10b5-1 | −1,690 | $42.60 | $72K | 43,254 |
| 2026-06-17 | Balachandran Madhavan Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,295 | 0 | ||
| 2026-06-17 | Balachandran Madhavan Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −6,390 | 0 | ||
| 2026-06-17 | Kaye Jack Director | Exercise or conversion 10b5-1 | +5,295 | $31.71 | $168K | 31,291 |
| 2026-06-17 | Kaye Jack Director | Sale 10b5-1 | −5,295 | $42.57 | $225K | 25,996 |
| 2026-06-17 | Kaye Jack Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,295 | 0 | ||
| 2026-06-15 | Balachandran Madhavan Director | Exercise or conversion 10b5-1 | +10,000 | $8.49 | $85K | 53,254 |
| 2026-06-15 | Balachandran Madhavan Director | Sale 10b5-1 | −10,000 | $27.85 | $279K | 43,254 |
| 2026-06-15 | Balachandran Madhavan Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2026-06-15 | Potts Jeannette Chief Legal Officer | Sale | −5,237 | $27.67 | $145K | 133,246 |
| 2026-06-11 | Meek David D. Director | Sale | −1,993 | $27.06 | $54K | 39,747 |
| 2026-06-11 | Gut Robert Director | Sale 10b5-1 | −2,726 | $27.06 | $74K | 32,259 |
| 2026-06-11 | O'Keefe Kylie Chief Customer & Strat Officer | Sale | −15,936 | $27.06 | $431K | 108,864 |
| 2026-06-11 | Springhorn Jeremy P. Director | Sale | −1,993 | $27.06 | $54K | 43,251 |
| 2026-06-11 | POST LEONARD E Director | Sale | −1,993 | $27.06 | $54K | 35,494 |
| 2026-06-11 | Kaye Jack Director | Sale | −1,993 | $27.06 | $54K | 25,996 |
| 2026-06-11 | Jacques Rachelle Suzanne Director | Sale | −1,993 | $27.06 | $54K | 33,903 |
| 2026-06-11 | Balachandran Madhavan Director | Sale | −1,993 | $27.06 | $54K | 43,254 |
| 2026-06-10 | Meek David D. Director | Grant or award | +7,550 | 41,740 | ||
| 2026-06-10 | Meek David D. Director | Grant or award · Stock Option (Right to Buy) | +13,980 | 13,980 |
Page 3 of 13 · 251 trades